EUVIMEDEUVIMED entdecken
Crossref

How Innate Immunity affects CRISPR/Cas9 Gene Editing

Julia K. Pfromm

Universitätsbibliothek Tübingen · 10.01.2023

DOI: 10.15496/publikation-76503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Universitätsbibliothek Tübingen, erschienen am 10.01.2023. Verfasst von Julia K. Pfromm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (Cas9) systems are powerful gene-editing tools that may facilitate causative treatments of inherited retinal diseases. The immunogenic potential of Cas9, a peptide of bacterial origin, was assessed using cellular models of human immunocompetent cells, including macroglial and microglial cell lines. Transfection of human immortalized microglia (IMhu) with Streptococcus pyogenes-Cas9 led to Cas9 expression but did not induce a pro-inflammatory innate immune response, with no induction of pro-inflammatory cytokine production measured. These results demonstrate no evidence of an immunogenic effect of Cas9 transfection in models of human microglial cells, adding another layer of confidence in the immunological safety of possible Cas9-mediated retinal gene therapies.

Schlagwörter

CRISPR/Cas9innate immunitySpCas9microgliamacrogliainflammatory cytokinesretinal gene therapyinherited retinal diseaseimmunological safety

Zitieren

APA

Pfromm, J. K. (2023). How Innate Immunity affects CRISPR/Cas9 Gene Editing. Universitätsbibliothek Tübingen. https://doi.org/10.15496/publikation-76503

Vancouver

Pfromm JK. How Innate Immunity affects CRISPR/Cas9 Gene Editing. Universitätsbibliothek Tübingen. 2023. doi:10.15496/publikation-76503

BibTeX
@article{Pfromm2023,
  author = {Pfromm, Julia K.},
  title = {How Innate Immunity affects CRISPR/Cas9 Gene Editing},
  journal = {Universitätsbibliothek Tübingen},
  year = {2023},
  doi = {10.15496/publikation-76503}
}
Kostenlos starten →